Pro-Choice Friday News Rundown

  • The POTUS, who is so pro-life he hasn’t fostered or adopted any children in need, has signed legislation that allows states to withhold federal Title X funds for family planning services from clinics that also provide abortions. But thankfully, the change won’t impact Arizona. (AZ Central)
  • For women in other states: Please know, we are listening and we know what’s at stake for all of you. We’re fighting. (Bustle)
  • Impoverished minority women will be ESPECIALLY endangered by this legislation: 80 percent of women who rely on Title X funding are well below the poverty line, and 21 percent are black and 32 percent are Latina. (Ebony)
  • Will absolutely all of my rundowns during this bleak era of GOP dominion include yet another story about how they’re trying their best to dismantle the Affordable Care Act and make us all poorer and sicker and closer to death so rich people can have tax cuts? Signs point to “yes.” (WaPo)
  • The list of the 25 cities with the highest STD rates doesn’t include anywhere in Arizona. Let’s keep it that way? (Insider Monkey)
  • California could be the first state in the country to require its public universities to offer abortion pills on campuses. (Mercury News)
  • Attorneys general from 16 states came out Thursday in support of a Planned Parenthood lawsuit challenging an Ohio law that would deny state and federal funds to organizations providing abortions. (HuffPo)
  • The zero-copay birth control we’ve come to enjoy via Obamacare is still the “law of the land,” but for how much longer? (Rewire)
  • Why does America offer only five versions of the IUD when Britain has 22??? (The Atlantic)
  • Arizona Sen. Jeff Flake, who is so pro-life he hasn’t fostered or adopted any children in need, got his you-know-what handed to him by constituents at his town hall last week! (AZ Central)
  • Television is a treasure trove of lies. Abortion depicted on the small screen is 20 times deadlier than in real life, where it’s actually safer for the woman than childbirth. (Slate)
  • New Maryland Bill Would Require Domestic Abusers to Wear GPS Trackers. (NY Mag)
  • Maryland is on a roll! Victims In Maryland No Longer Have To Prove They “Fought Back” For Their Rapes To Be Crimes. (HuffPo)
  • With all of the “out and proud” anti-choice zealots in our government who are proud to admit they think women should be forced to give birth whether they wish to or not, the last thing we need is a phony, wolf-in-sheep’s-clothing turncoat like Illinois Gov. Bruce Rauner. He claimed to be pro-choice on the campaign trail in 2013, so why in the hell is he now indicating he will veto a bill protecting the right to choose and permitting coverage of abortion in state health plans and Medicaid? Can the pro-choice voters of Illinois spearhead a gubernatorial recall over this? (Rewire)
  • It would do Gov. Rauner a lot of good to remember that abortion is a matter of economic life or death for women and use the power of his office to help rather than hurt the economic fates of women. (Rewire)
  • “Dystopian” doesn’t even BEGIN to describe how the world would look without Planned Parenthood. (HuffPo)

STD Awareness: Shaving, Waxing, and Trimming, Oh My!

Last month, the connection between body-hair removal and sexually transmitted diseases (STDs) once again gave rise to a flurry of headlines. Media had previously reported on “studies” purporting that the popularity of waxing is leading to the extinction of pubic lice, or that shaving increases risk for a little-known STD called molluscum contagiosum.

The idea that waxing one’s nether regions is tantamount to habitat destruction for the lowly pubic louse makes a certain amount of sense. But was it really true that waxing was leading to diminished pubic-lice populations, or just a case of the media blowing an obscure medical factoid out of proportion? Ditto with the claims about molluscum contagiosum — though they were based on perfectly plausible premises, having to do with shaving causing microscopic skin injuries that create openings for infectious viruses, the average reader might not have been able to rely on a journalist’s ability to translate a scientific article from “medical-ese” into an easy-to-understand, yet fully nuanced, magazine blurb.


The case isn’t closed on the link between body-hair removal and STDs.


As we’ve written before, the reporting in the popular media left out important details — such as the fact that these weren’t studies at all, but rather educated guesses based on observations, published as letters to the editor. No one was comparing pubic lice infestations or sexually transmitted infections between groups of people with and without pubic hair.

Until now.

The medical journal Sexually Transmitted Infections recently published a study based on a survey of 7,470 American adults who had had at least one sexual partner. The salient point the media pounced on was that removing pubic hair increases STD risk by 400 percent: NPR screamed that “Going Bare Down There May Boost The Risk Of STDs,” Time proclaimed “Grooming is linked to a higher risk of STIs,” and The Guardian spooked readers with a rather tasteless piece about “the health dangers of bikini waxing.” Even Saturday Night Live’s Weekend Update got in on the action, albeit with a crude joke about old men’s genitals.

But let’s leave headlines behind and delve right into the medical journal itself. Continue reading

STD Awareness: Fully Antibiotic-Resistant Gonorrhea Is on the Horizon

shot-in-armWe’ve been anticipating its arrival for years now, but earlier this fall, the Centers for Disease Control and Prevention (CDC) finally made an announcement: Cases of gonorrhea resistant to the last drugs we use to cure it are emerging.

Over the years, gonorrhea has evolved resistance to every drug we’ve thrown at it — sulfonamides, penicillins, tetracyclines, macrolides, fluoroquinolones, and narrow-spectrum cephalosporins. The last line of defense we have is a one-two punch of a pair of antibiotics: azithromycin and ceftriaxone. By using two drugs, we can delay the inevitable evolution of antibiotic resistance by attacking the bacteria in two vulnerable locations, rather than just one, making it more difficult for the bug to mount a defense and pass on its superior survival skills to subsequent generations.


Prevention is paramount: Stop the spread of antibiotic resistance by practicing safer sex!


Unfortunately, we could only stave off the inevitable for so long. At their conference in September, the CDC announced a cluster of gonorrhea infections that are highly resistant to azithromycin, and that fall prey only to high doses of ceftriaxone. As gonorrhea’s tolerance to ceftriaxone increases, the infection will get more and more difficult to cure.

This cluster of drug-resistant cases was identified in Honolulu in April and May of this year, with five infections showing “dramatic” resistance to azithromycin, as well as reduced vulnerability to ceftriaxone. The good news is that these cases were cured with higher-than-usual doses of antibiotics, but the bad news is that dosages can only climb so high before a drug is no longer considered to be an effective treatment. Continue reading

STD Awareness: Gonorrhea’s Ever-Growing Resistance to Antibiotics

gonococci

Gonococci, the bacteria that cause gonorrhea.

Ever since the advent of effective antibacterial therapies less than a century ago, humans with access to these drugs can easily cure gonorrhea. Most of us in the developed world have forgotten that this disease was once a leading cause of infertility in women and blindness in babies — sulfa drugs and antibiotics not only erased these infections from our bodies, they also erased memories of gonorrhea’s dangers from our collective consciousness.


There are two drugs remaining to treat gonorrhea, and resistance to them is climbing higher as the years march on.


Unfortunately, thanks to their talent for genetic gymnastics, gonococci, the bacteria that cause gonorrhea, have been evolving resistance to every drug we’ve thrown at them — to tetracycline, to penicillin, and more recently to fluoroquinolones. One class of antibiotics remains to treat gonorrhea: cephalosporins. In 2013, Centers for Disease Control and Prevention (CDC) Director Tom Frieden warned that we could find ourselves in a “post-antibiotic era” – unless we take precautions. And, just two weeks ago, the latest study from the CDC’s Gonococcal Isolate Surveillance Project sounded the alarm that the post-antibiotic era is drawing ever closer, especially when it comes to gonorrhea.

Azithromycin and ceftriaxone, the two drugs that are used in combination to deliver a one-two punch to invading gonococci, are the best antibiotics remaining in our arsenal. Azithromycin is taken by mouth, while ceftriaxone is administered by a shot, and when taken together they team up to target different weak points in gonococci’s armor. Azithromycin interferes with the bacteria’s ability to make proteins, shutting the cells down, while ceftriaxone causes the cell wall to fall apart. However, the gonococci can acquire resistance. For example, in the case of azithromycin, a resistant bacterium can spit out the drug before it has a chance to kill it, or it can change the shape of its protein-making apparatus such that the drug can’t attach to it.  Continue reading

STD Awareness: June Is National Congenital Cytomegalovirus Awareness Month

CMVPop quiz: Can you name the virus that most commonly infects developing fetuses when they are still in the womb?

Here’s a hint: June is National Congenital Cytomegalovirus Awareness Month.

In case that clue didn’t make it obvious enough, I’ll tell you the answer. The most common infection among developing fetuses is caused by a virus you might not have heard of: cytomegalovirus, or CMV. Around 30,000 children are born with this infection every year, and some of these babies will go on to develop serious problems because of it. National Congenital Cytomegalovirus Awareness Month is a time to learn about how CMV can affect pregnancy.


Cytomegalovirus can damage developing brain cells early in an embryo’s gestation.


This year, it might be of even greater interest, given the parallels that can be drawn between CMV and Zika virus, the emerging pathogen that has been dominating headlines lately. First of all, both CMV and Zika virus can be transmitted sexually, though they are not the first things you think of when the topic of STDs comes up, as they are overshadowed by more famous sexually transmitted viruses like herpes and human papillomavirus. While many of us are infected with CMV as children, we can also be infected as adults, often through sexual transmission — the virus can be found in cervical and vaginal secretions, saliva, and semen. The sexual transmission of Zika virus is not as well understood, but we know it can be found in semen, and there are documented cases of men passing the virus to sex partners through vaginal and anal intercourse. It might even be transmitted from a male to a partner by oral sex.

Second of all, both CMV and Zika virus are associated with birth defects. However, while the connection between CMV and birth defects has been known to us for decades, it was only in April that the Centers for Disease Control and Prevention concluded that Zika virus can cause fetal brain defects (though we’re still waiting for conclusive proof). Microcephaly is probably the most infamous of the birth defects associated with Zika virus, as well as CMV, but it’s not well defined. When you get down to it, though, microcephaly just refers to an abnormally small head, which itself might be indicative of a brain that has failed to develop fully. Continue reading

STD Awareness: Which STDs Are Resistant to Antibiotics?

pillsYou’ve probably heard of MRSA, which is pronounced “mersa” and stands for methicillin-resistant Staphylococcus aureus — a strain of bacteria that is resistant to methicillin, as well as pretty much every other antibiotic out there. MRSA is an example of evolution by natural selection — what didn’t kill its ancestors made them stronger, spawning a drug-resistant strain.


There are drug-resistant strains of gonorrhea, trichomoniasis, and syphilis.


Evolution is the force behind life’s diversity. Normally, diversity is a good thing — but when it comes to microbes that cause diseases like gonorrhea, trichomoniasis, and syphilis, these organisms’ ability to evolve new defenses against our antimicrobial drugs isn’t good for us.

STDs have plagued us for millennia, but it wasn’t until the 20th century that we finally developed antibiotics, which gave us a powerful tool against many of our most formidable sexually transmitted foes. Suddenly, scourges like gonorrhea and syphilis could be quickly and easily treated with a dose of penicillin.

Problem solved, right? Nope. Enter evolution by natural selection. Continue reading

STD Awareness: Ceftriaxone-Resistant Gonorrhea

syringeNestled in the throat of a Japanese woman was a collection of clones that scientists abducted from their temporary habitat and christened H041 — a humdrum moniker for a strain of bacteria that would burn headlines in medical journals. Though the bacteria never caused symptoms in their host, they lingered in her throat from at least January until April of 2009, when a swab finally tested negative. Rather than succumbing to repeated bombardment by an antibiotic called ceftriaxone, the infection probably just went away on its own — as oral gonorrhea infections tend to do.


Resistance to ceftriaxone, our last good gonorrhea drug, has been reported in Japan, Australia, Sweden, France, and Spain.


The emergence of antibiotic-resistant gonorrhea is considered one of the most pressing problems in infectious disease — just two years ago, the Centers for Disease Control and Prevention named it an “urgent threat.” We have one remaining first-line gonorrhea treatment left: extended-spectrum cephalosporins, which include cefixime, which is taken orally, and ceftriaxone, which is administered as a shot. Resistance to cefixime was first documented in 1999, leaving ceftriaxone as our best remaining option, and the CDC’s first choice for treating gonorrhea. There are no good alternatives to ceftriaxone remaining, which is why reports of ceftriaxone-resistant gonorrhea are so deeply troubling.

What made H041 special was that it was the first extensively drug-resistant strain of Neisseria gonorrhoeae, the bacteria that cause gonorrhea. With an unusually high level of resistance to ceftriaxone — four to eight times higher than the previous record holder — the strain was also resistant to a slew of other antibiotics: penicillin and its relatives, fluoroquinolones, macrolides, tetracycline, trimethoprim-sulfamethoxazole, chloramphenicol, nitrofurantoin, cefpodoxime, cefixime, ciprofloxacin, and levofloxacin — and had reduced susceptibility to azithromycin to boot.

Another thing that made H041 special — as special as clones can be, anyway — is that it never reappeared. After its discovery, researchers in Kyoto and Osaka intensified their surveillance, trying to uncover it again and track its spread through the population. However, their search for H041 turned up empty handed. But other ceftriaxone-resistant strains have been documented around the world. Continue reading